Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.

Christian Meier Richard EastellDominique D PierrozNancy E LaneNasser Al-DaghriAtsushi SuzukiNicola NapoliAmbrish MithalMarlene ChakhtouraGhada El-Hajj Fuleihan Serge Livio Ferrari

Published in: The Journal of clinical endocrinology and metabolism (2023)

Several biochemical markers and hormonal levels related to bone and/or glucose metabolism have been associated with skeletal parameters in diabetes. Currently, only HbA1c levels seem to provide a reliable estimate of fracture risk, while bone turnover markers could be used to monitor the effects of anti-osteoporosis therapy.

Keyphrases

bone mineral density
postmenopausal women
body composition
soft tissue
bone loss
type diabetes
bone regeneration
cardiovascular disease
stem cells
mesenchymal stem cells
skeletal muscle
polycystic ovary syndrome